Novartis Investigative Site

Numakunai 020-8505

0 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Renal Cell, Ovarian Cancer

Studies at this site

• Pazopanib Versus Sunitinib in the Treatment of Locally Advanced and/or Metastatic Renal Cell Carcinoma — Completed
• Efficacy and Safety of Pazopanib Monotherapy After First Line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer — Completed